Literature DB >> 3287010

Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update.

S J Taussig1, S Batkin.   

Abstract

After a short description of the uses of pineapple as folk medicine by the natives of the tropics, the more important new pharmaceutical applications of bromelain, reported between 1975 and 1978, are presented. Although the exact chemical structure of all active components of bromelain is not fully determined, this substance has shown distinct pharmacological promise. Its properties include: (1) interference with growth of malignant cells; (2) inhibition of platelet aggregation; (3) fibrinolytic activity; (4) anti-inflammatory action; (5) skin debridement properties. These biological functions of bromelain, a non-toxic compound, have therapeutic values in modulating: (a) tumor growth; (b) blood coagulation; (c) inflammatory changes; (d) debridement of third degree burns; (e) enhancement of absorption of drugs. The mechanism of action of bromelain affecting these varied biological effects relates in part to its modulation of the arachidonate cascade.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287010     DOI: 10.1016/0378-8741(88)90127-4

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  45 in total

1.  Role of Oral Enzymes in Post Operative Septoplasty Cases.

Authors:  Manpreet Singh Nanda; Mandeep Kaur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-12-05

2.  Effect of bromelain on milk yield, milk composition and mammary health in dairy goats.

Authors:  A Contreras; M J Paape; R H Miller; J C Corrales; C Luengo; A Sánchez
Journal:  Trop Anim Health Prod       Date:  2008-07-27       Impact factor: 1.559

3.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

4.  Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity.

Authors:  S Batkin; S J Taussig; J Szekerezes
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease.

Authors:  Eric R Secor; William F Carson; Michelle M Cloutier; Linda A Guernsey; Craig M Schramm; Carol A Wu; Roger S Thrall
Journal:  Cell Immunol       Date:  2005-12-06       Impact factor: 4.868

6.  Bromelain reversibly inhibits invasive properties of glioma cells.

Authors:  B B Tysnes; H R Maurer; T Porwol; B Probst; R Bjerkvig; F Hoover
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

7.  Comparison of proteolytic, cytotoxic and anticoagulant properties of chromatographically fractionated bromelain to un-fractionated bromelain.

Authors:  Samina Badar; Mohamed Azarkan; Ahmed H Mekkawy; Javed Akhter; Krishna Pillai; Rachida El Mahyaoui; Kevin Ke; Lauren Cavanaugh; David L Morris
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

8.  Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; Winston Liauw; David Lawson Morris
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  Bromelain treatment decreases neutrophil migration to sites of inflammation.

Authors:  David J Fitzhugh; Siqing Shan; Mark W Dewhirst; Laura P Hale
Journal:  Clin Immunol       Date:  2008-05-14       Impact factor: 3.969

Review 10.  Optimal treatment of venous (stasis) ulcers in elderly patients.

Authors:  C Hansson
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.